MedTrace Logo

Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children

NCT05870618 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 480

Last updated 2023-05-23

No results posted yet for this study

Summary

This study is to evaluate the immunogenicity and safety of DTaP or DT given in children aged 6 years.

Conditions

  • Vaccine Reaction

Interventions

BIOLOGICAL

vaccinate with DTap

vaccinate with DTap

BIOLOGICAL

vaccinate with DT

vaccinate with DT

Sponsors & Collaborators

  • China National Biotec Group Company Limited

    collaborator INDUSTRY

  • Zhejiang Provincial Center for Disease Control and Prevention

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
72 Months
Max Age
84 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2023-12-31
Completion
2024-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05870618 on ClinicalTrials.gov